7:00 am – 8.00 am
11th May
Registration and Welcome
8:00 am – 8:30 am
11th May
Opening Ceremony
- Welcome address by the Congress Chair – Prof Dr Alina Daniela Tanase
- Introduction to the Congress theme and objectives – President of Romanian National College of Physicians – Prof Dr Daniel Coriu
8:30 am – 9:30 am
11th May
Plenary Session 1 – “Transplant Trek: From NOW to WOW – State of the Art in HSCT in 2024“
Chair: Stefan Ciurea, Angela Dascalescu
- Expanding Post-transplant Cyclophosphamide to All Allogeneic Transplants – Is This the New Standard? Chris Kanakry
- CAR T-cell Therapy in Multiple Myeloma – Will It Replace Stem Cell Transplant? Arun Wiita
9:30 am – 10:00 am
11th May
Educational session: Conditioning regimen: Thiotepa, a new standard of care?
- Andrea Bacigalupo
10:00 am – 11.00 am
11th May
New Frontiers: Improving Transplant Outcomes for Patients with ALL
Chair: Gabriel Ghiaur, Andrei Colita
- UCI Perspective – Stefan Ciurea
- Johns Hopkin’s Perspective – Jon Webster.
11:00 am – 11.30 am
11th May
Coffee Break and Networking
11:30 am – 12:30 pm
11th May
Special Session – “Think Big in the Small World: Predicting the Risk of HSCT”
Chair: Anca Colita, Horia Bumbea
- Prognostic Models in Allogeneic Transplants – Mohamed Sorror
- Tailoring Transplant Approaches for Older Adults – Andrew Artz
12:30 am – 1:00 pm
11th May
Johnson & Johnson Symposium
Evolving treatment options în transplant eligible multiple myeloma, – Dr. Angela Smaranda Dăscălescu
1:00 pm – 2:00 pm
11th May
Lunch Break
2:00 pm – 2:30 pm
11th May
CAR-T – paradigm shift in cancer treatment
Dr. Lavinia Lipan – Novartis Medical Symposium
2:30 pm – 3:30 pm
11th May
Keynote Lectures – Introduction Ciprian Tomuleasa
Translational Research in Hematology and Oncology – William Kaelin Jr – Nobel Prize Laureate 2019, Harvard Medical School, Boston, USA
3:30 pm – 4:30 pm
11th May
Plenary session 2 – “Advancements and Insights in Stem Cell Transplantation”
Chair: Alina Tanase, Ileana Constantinescu
- Novel Therapeutic Approaches in Stem Cell Transplantation for T Cell Lymphomas – Shigeo Fuji
- AlloHCT Strategies for mature T cell lymphomas – Jennifer Kanakry
4:30 pm – 5:00 pm
11th May
Latest advancements in CMV management after HSCT: how long is long enough?
Alina Tanase – MSD Medical Symposium
5:00 pm – 7:00 pm
11th May
SRTM Session
Chair: Laura Stefan, Cristina Jercan
- Stroe Alexandra Stefania “Evaluare comparative a regimurilor de salvare utilizate la pacientii cu LMNH R/R inainte de autoTCSH”/ “Comparism of current salvage chemotherapy regimens used in patients with R/R lymphoma prior to autotologous stem cell transplantation”
- Diana-Marina Fortoes ; Autotransplantul Medular si Terapia de Inductie DVTD la Pacientii cu Mielom Multiplu: Experienta unui Centru
- Horia Bumbea: Perspective genomice asupra hematopoiezei clonale în transplantul de celule stem hematopoietice și screening-ul donatorilor
- Miruna Tirnovan “Rolul transplantului de microbiota fecale in GVHD digestive” / “The role of fecal microbiota transplantation in gut GVHD”
- Ana Ilinescu “A case study of ALL with pulmonary GVHD and multifaceted therapeutic approaches”
- Alexandra Oana Enache “Complexity and challenges of pulmonary complications in HSCT – a clinical case presentation”
- Anca Orezanu “The impact of hematopoietic stem cell transplantation on the health of female reproductive system”
- Andrei Orezanu “The impact of chronic urological graft-versus-host disease on patients’ quality of life following post-hematopoietic stem cell transplantation.”
- Cristina Jercan, “Refractory Pediatric Neuroblastoma: Exploring Haploidentical and Tandem Stem Cell Transplantation Approaches”




